Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma

Cancer

Volumn 71, Issue 1, 1993, Pages 26-35

  Imai, Haruhiko ^a   Nakano, Yoshiyuki ^b   Kiyosawa, Kendo ^b   Tan, Eng M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antinuclear antibody; autoantibody; autoimmune hepatitis; chronic hepatitis; hepatocellular carcinoma; liver cirrhosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CANCER DIAGNOSIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS; HEPATITIS C; HUMAN; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGE; PRECANCEROUS CONDITIONS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027392631     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930101)71:1<26::AID-CNCR2820710106>3.0.CO;2-N     Document Type: Article

References (54)

1. Smooth muscle antibody in malignant disease
2. Antinuclear antibodies in patients with malignancies
3. Malignancy associated with antinuclear antibodies
4. Non‐organ specific autoantibodies in malignant diseases
5. Autoantibodies in patients with bronchial carcinoma
6. Autoantibodies in patients with carcinoma of the breast: correlation with prognosis
7. Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases
8. Autoantibodies in cancer patients
9. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients
10. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma
11. Rheumatoid factors in the sera of patients with gastrointestinal carcinoma
12. Serum autoantibodies in patients with hepatocellular carcinoma: the clinical significance of antinuclear antibody
13. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionopathy
14. The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients, and in rheumatoid‐like disease
15. Autoantibodies in three populations of Burkitt's lymphoma patients
16. Follow‐up of antibodies against single‐stranded DNA in patients with haematological malignancies
17. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration
18. Cloning of a leucine‐zipper protein recognized by the sera of patients with antibody‐associated paraneoplastic cerebellar degeneration
19. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer‐associated retinopathy
20. Autoantibodies in neoplasia: an unresolved enigma
21. The spectrum of complement‐fixing antinuclear antibodies in patients with hepatocellular carcinoma
22. Detection of immunoglobulin G. antibodies in melanoma sera reactive with intracellular proteins
23. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients
24. Detection of circulating antibodies against c‐myc protein in cancer patient sera
25. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
26. Autoantibodies in early breast cancer: a stage‐related phenomenon?
27. A lupus antibody syndrome associated with hypernephroma
28. Hemolytic anemia associated with an ovarian tumor
29. Autoantibodies in paraneoplastic syndromes associated with small‐cell lung cancer
30. Cancer‐associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic‐nerve, and cancer cells
31. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma
32. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus
33. A classification of chronic hepatitis
34. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis
35. Rapid isolation of nucleoli from detergent purified nuclei of various tumor and tissue culture cells
36. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
37. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications
38. High resolution twodimensional electrophoresis of basic as well as acidic proteins
39. Subnucleosome structures as substrates in enzyme‐linked immunosorbent assays
40. A monoclonal antibody against a 135–K Golgi membrane protein
41. Relationship between hepatocellular carcinoma and cirrhosis
42. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine
43. Primary hepatocellular carcinoma
44. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan
45. Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma
46. Screening methods for early detection of hepatocellular carcinoma
47. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
48. Hepatocarcinogenicity of the woodchuck hepatitis virus
49. Hepatitis C viremia in adults with type 2 autoimmune hepatitis
50. Non‐A, non‐B hepatitis specific antibodies directed at host‐derived epitope: implication for an autoimmune process
51. Anti‐GOR and hepatitis C virus in autoimmune liver diseases
52. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies
53. Antigenic characterization of human hepatocellular carcinoma: development of in vitro and in vivo immunoassays that use monoclonal antibodies
54. Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies